Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)

PHASE2TerminatedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2007

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

BMS-275183 (oral taxane)

Trial Locations (30)

Unknown

Local Institution, Burlington

Local Institution, St Louis

Local Institution, Morganton

Local Institution, Cleveland

Local Institution, Charleroi

Local Institution, Leuven

Local Institution, Montreal

Local Institution, Thunder Bay

Local Institution, Toronto

Local Institution, Saint-Jérôme

Local Institution, Belfort

Local Institution, Besançon

Local Institution, Poitiers

Local Institution, Saint-Herblain

Local Institution, Strasbourg

Local Institution, Tours

Local Institution, Napoli

Local Institution, Orbassano Torino

Local Institution, Perugia

Local Institution, Roma

Local Institution, Amsterdam

Local Institution, Maastricht

Local Institution, Barcelona

Local Institution, Madrid

Local Institution, Cambridge

Local Institution, Glasgow

Local Institution, Plymouth

Local Institution, London

Local Institution, Northwood

Local Institution, Oxford

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY